|
|
|
|
|
|
|
M T W Th Fri |
|
12 June, 2026 |
|
|
sponsored by
|
|
|
|
Secure Your Commercial Supply
|
| To support your commercial success, we're expanding our large-scale biologics drug product manufacturing capabilities, providing end-to-end solutions through our global network and enabling seamless integration of drug substance and drug product. |
|
|
|
|
|
|
|
|
|
|
|
|
|
The pharma industry suffered a couple of setbacks this week in its fight to reel in the 340B federal drug discount program. Drugmakers have been challenging state laws that prohibit them from putting limits on the use of contract pharmacies under 340B. But on Wednesday, a federal judge rejected AbbVie’s case against Colorado’s state law. AbbVie, Novartis and the industry trade group PhRMA also lost their attempt to preliminarily block Washington’s state law on Tuesday.
But the fight isn’t over yet: Similar lawsuits continue to make their way through the court system. We'll keep you posted on those as they're determined. |
|
|
|
Nicole DeFeudis |
Senior Reporter, Endpoints News
@Nicole_DeFeudis
|
|
|
|
|
|
|
by Karen Weintraub
|
Amgen has asked the FDA to review evidence that its drug Tavneos (avacopan), which treats a rare form of vasculitis, is worth keeping on the... | |
|
|
|
 |
|
|
|
by Ngai Yeung
|
Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences. The... | |
|
|
|
|
|
|
|
|
by Anna Brown
|
WuXi AppTec has lodged a claim against the Department of Defense following its addition to a list of companies associated with the Chinese military. Under... | |
|
|
|
|
|
|
by Max Gelman
|
GSK’s $10.6 billion buyout of Nuvalent, announced Tuesday, was the largest in the company’s history. But did new CEO Luke Miels get a discount... | |
|
|
|
 |
|
|
|
by Andrew Dunn
|
In combing through thousands of C-suite pay packages worth billions of dollars, it’s rare for a line item to stick out. Every once in a... | |
|
|
|
 |
|
|
|
by Alex Hoffman, Kyle LaHucik, Max Bayer
|
|
|
|
